ARCTURUS THERAPEUTICS HOLDIN (ARCT)

US03969T1097 - Common Stock

15.48  +0.64 (+4.31%)

After market: 15.48 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
12.4M
30.53%
206M
1,561.29%
166.799M
-19.03%
179.02M
7.33%
187.45M
4.71%
347.24M
85.24%
514.75M
48.24%
774.91M
50.54%
1.007B
29.95%
1.202B
19.36%
1.39B
15.64%
EBITDA
YoY % growth
-201.71M
-185.63%
13.73M
106.81%
-75.248M
-648.06%
-99.45M
-32.16%
-144.942M
-45.74%
-190.526M
-31.45%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-202.9M
-183.78%
12.2M
106.01%
-78.205M
-741.02%
-80.694M
-3.18%
-69.995M
13.26%
33.109M
147.30%
223.36M
574.62%
503.66M
125.49%
716.66M
42.29%
1.218B
69.96%
1.37B
12.48%
Operating Margin
-1,636.29%5.92%-46.89%-45.08%-37.34%9.53%43.39%65.00%71.17%101.33%98.56%
EPS
YoY % growth
-7.74
-128.32%
0.34
104.39%
-1.04
-405.88%
-2.50
-140.00%
-2.02
18.91%
0.78
138.41%
3.60
363.61%
8.41
133.32%
13.21
57.06%
15.74
19.14%
19.82
25.95%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.58
-80.06%
-0.63
37.10%
0.03
104.25%
-0.54
-107.92%
-0.20
65.48%
1.68
367.57%
0.82
2,918.37%
2.42
547.17%
3.15
1,682.05%
Revenue
Q2Q % growth
46.844M
37.82%
54.053M
42.20%
76.547M
53.53%
66.666M
59.97%
75.736M
61.68%
122.72M
127.04%
126.44M
65.18%
194.73M
192.10%
234.91M
210.17%
EBITDA
Q2Q % growth
-33.323M
-117.59%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-17.13M
6.25%
-20.172M
33.67%
-796.62K
96.23%
-1.627M
84.85%
7.224M
142.17%
73.197M
462.87%
77.162M
9,786.17%
104M
6,492.53%
158.6M
2,095.46%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.26
57.38%
-1.240.9879.04%
Q2 2024
Q2Q % growth
-0.64
67.68%
-1.630.9960.74%
Q1 2024
Q2Q % growth
-1.00
-153.48%
-1.210.2117.53%
Q4 2023
Q2Q % growth
-0.32
-107.22%
-1.010.6968.38%
Q3 2023
Q2Q % growth
-0.61
54.14%
-1.731.1264.65%
Q2 2023
Q2Q % growth
-1.98
-141.46%
-0.21-1.77-821.08%
Q1 2023
Q2Q % growth
1.87
196.39%
0.061.812,968.34%
Q4 2022
Q2Q % growth
4.43
401.36%
1.003.43343.79%
Q3 2022
Q2Q % growth
-1.33
35.12%
-1.850.5228.13%
Q2 2022
Q2Q % growth
-0.82
60.39%
-1.941.1257.69%
Q1 2022
Q2Q % growth
-1.94
9.77%
-1.47-0.47-32.29%
Q4 2021
Q2Q % growth
-1.47
-17.60%
-1.760.2916.39%
Q3 2021
Q2Q % growth
-2.05
-122.83%
-1.62-0.43-26.20%
Q2 2021
Q2Q % growth
-2.07
-276.36%
-2.190.125.51%
Q1 2021
Q2Q % growth
-2.15
-220.90%
-1.28-0.87-68.19%
Q4 2020
Q2Q % growth
-1.25
-64.47%
-0.90-0.35-39.25%
Q3 2020
Q2Q % growth
-0.92
-64.29%
-0.50-0.42-85.11%
Q2 2020
Q2Q % growth
-0.55
-685.71%
-0.560.012.35%
Q1 2020
Q2Q % growth
-0.67
-3.08%
-0.62-0.05-8.19%
Q4 2019
Q2Q % growth
-0.76
-850.00%
-0.54-0.22-39.83%
Q3 2019
Q2Q % growth
-0.56
-33.33%
-0.37-0.19-51.66%
Q2 2019
Q2Q % growth
-0.07
92.93%
-0.650.5889.19%
Q1 2019
Q2Q % growth
-0.65
1.52%
-0.59-0.06-10.35%
Q4 2018
Q2Q % growth
-0.08 -0.490.4183.83%
Q3 2018
Q2Q % growth
-0.42 -0.570.1526.47%
Q2 2018
Q2Q % growth
-0.99 -0.71-0.28-38.66%
Q1 2018
Q2Q % growth
-0.66 -0.670.011.96%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
41.673M
-7.68%
37.329M4.344M11.64%
Q2 2024
Q2Q % growth
49.859M
373.99%
22.13M27.729M125.30%
Q1 2024
Q2Q % growth
38.012M
-52.32%
17.895M20.117M112.42%
Q4 2023
Q2Q % growth
33.989M
-78.80%
38.613M-4.624M-11.98%
Q3 2023
Q2Q % growth
45.14M
236.87%
16.182M28.958M178.95%
Q2 2023
Q2Q % growth
10.519M
-61.18%
49.472M-38.953M-78.74%
Q1 2023
Q2Q % growth
79.729M
1,433.25%
38.694M41.035M106.05%
Q4 2022
Q2Q % growth
160.3M
2,663.79%
74.137M86.163M116.22%
Q3 2022
Q2Q % growth
13.4M
458.33%
3.492M9.908M283.73%
Q2 2022
Q2Q % growth
27.1M
1,255.00%
2.131M24.969M1,171.70%
Q1 2022
Q2Q % growth
5.2M
147.62%
6.423M-1.223M-19.04%
Q4 2021
Q2Q % growth
5.8M
163.64%
15.01M-9.21M-61.36%
Q3 2021
Q2Q % growth
2.4M
4.35%
22.191M-19.791M-89.18%
Q2 2021
Q2Q % growth
2M
-13.04%
2.362M-362K-15.33%
Q1 2021
Q2Q % growth
2.1M
-19.23%
2.59M-490K-18.92%
Q4 2020
Q2Q % growth
2.2M
-26.67%
2.405M-205K-8.52%
Q3 2020
Q2Q % growth
2.3M
-30.30%
3.064M-764K-24.93%
Q2 2020
Q2Q % growth
2.3M
-77.45%
3.61M-1.31M-36.29%
Q1 2020
Q2Q % growth
2.6M
-40.91%
5.069M-2.469M-48.71%
Q4 2019
Q2Q % growth
3M
-60.53%
3.722M-722K-19.40%
Q3 2019
Q2Q % growth
3.3M
-2.94%
6.014M-2.714M-45.13%
Q2 2019
Q2Q % growth
10.2M
325.00%
3.428M6.772M197.55%
Q1 2019
Q2Q % growth
4.4M
83.33%
3.13M1.27M40.58%
Q4 2018
Q2Q % growth
7.6M 3.013M4.587M152.24%
Q3 2018
Q2Q % growth
3.4M 2.434M966K39.69%
Q2 2018
Q2Q % growth
2.4M 3.641M-1.241M-34.08%
Q1 2018
Q2Q % growth
2.4M 1.734M666K38.41%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS12.92% -308.45% 23.96% 19.18%
Revenue-0.07% -39.13% -5.03% -5.41%